Advertisement
Home Local Maryland Government Announcement Originally published July 31, 2013

TODAY: GOVERNOR O’MALLEY TO HIGHLIGHT INVESTMENTS IN BIOTECHNOLOGY AT UNIVERSITY OF MARYLAND’S BIOPARK



GOVERNOR O’MALLEY TO HIGHLIGHT INVESTMENTS IN BIOTECHNOLOGY
AT UNIVERSITY OF MARYLAND’S BIOPARK


Will tour PathSensors and Noxilizer Companies

ANNAPOLIS, MD (July 31, 2013) – TODAY, July 31, Governor Martin O’Malley will visit University of Maryland’s BioPark where he will highlight the integral role biotechology plays in Maryland’s innovation economy. During his visit, the Governor will tour PathSensors and Noxilizer companies.

WHEN: 10:30 a.m. on Wednesday, July 31, 2013

WHERE: University of Maryland BioPark, 800 W. Baltimore St. Baltimore, MD

More than 600 people work in 30 companies at the University of Maryland BioPark, moving us toward cures for diseases like cancer, malaria and diabetes. It is this innovative, collaborative, job-creating, and life-saving work that continues to allow Maryland to compete and win in a 21st century economy.


About University of Maryland’s BioPark

The mission of the BioPark is to create a university-associated research park that accelerates biotechnology commercialization and economic development in the surrounding community and throughout the region.

For early-stage to mature bioscience companies, the BioPark offers a sophisticated laboratory and office environment on the University's vibrant academic medical center campus. In 2007, the Association for University Research Parks (AURP) named the BioPark the "Emerging University Research Science Park of the Year."

About PathSensors and Noxilizer

PathSensors, Inc., located in the University of Maryland BioPark in downtown Baltimore, Maryland, is a BioScience company specializing in pathogen detection, identification and monitoring in the biosecurity and food processing and testing markets. PathSensors, Inc., creates high technology jobs in the greater Baltimore downtown region.

Noxilizer has a unique and superior room temperature NO2-based sterilization technology that is revolutionizing two major sterilization markets — medical device/ pharmaceutical/biotechnology manufacturing and hospitals. In the manufacturing market, Noxilizer provides sterilization services for medical devices and drug/device combination products. Noxilizer sells the RTS 360 Industrial NO2 Sterilizer to companies who sterilize products in-house and also offers contract sterilization services. In hospitals, Noxilizer is developing a system especially for sensitive, high-tech equipment used in minimally-invasive surgical procedures. Noxilizer is headquartered in Baltimore, MD with offices in the US and Japan.